Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd announced it will release its full year results for the financial year ending June 30, 2025, on August 22, 2025. The announcement includes an invitation for investors to join a live webcast and Q&A session with key executives. This release is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd is a neuroscience technology company specializing in optimizing brain health assessments to advance the development of new medicines and enable earlier clinical insights in healthcare. The company offers rapid, reliable, and sensitive computerized cognitive tests and supports partners with electronic clinical outcome assessment solutions. Cogstate has been serving biopharmaceutical companies, academic institutions, and healthcare providers for over 20 years, focusing on digital measures of cognition that are easy to use and self-administered.
YTD Price Performance: 63.16%
Average Trading Volume: 83,990
Technical Sentiment Signal: Buy
Current Market Cap: A$290M
For an in-depth examination of CGS stock, go to TipRanks’ Overview page.